29 August 2024 in The Laryngoscope
10 July 2024 in The Laryngoscope
Objective: To identify patient‐reported outcome measures (PROMs) used to measure adult obstructive sleep apnea (OSA)‐related quality of life in sleep surgery and analyze key psychometric properties in the original design and development of each PROM.Data Sources: PubMed, Web of Science, Embase, PsychINFO, and CINAHL.Review Methods: A systematic review was performed using Preferred Reporting Items for Systematic Reviews and Meta‐analyses (PRISMA) guidelines. Disease‐specific instruments assessing sleep‐related quality of life that were used in sleep surgery studies and validated in patients with sleep disorders were included. The Consensus‐based Standards for the Selection of Health Status Measurement Instruments (COSMIN) criteria were used to evaluate methodological quality.Results: A total of 2494 abstracts were retrieved, and 216 underwent full‐text review. Seven PROMs assessing sleep‐related quality of life were identified. Only one (14%) PROM (SAQLI) was developed using both patient and physician input, and none were rated as “adequate” for content validity. Two PROMs utilized patients with sleep‐disordered breathing during content development and none specifically queried patients considering surgery. Six (86%) PROMs demonstrated “very good” analysis of internal consistency per COSMIN criteria, and six (86%) included data on test–retest reliability.Conclusion: Several PROMs are utilized in sleep‐related quality‐of‐life assessments for patients treated with OSA surgery. The measurement properties of these PROMs are of variable quality, and notably, no PROMs meet adequate quality measurements for content validity. New and updated PROMs for OSA‐related quality of life should consider input from sleep surgery patients and providers. Laryngoscope, 134:4838–4846, 2024
7 March 2025 in Otolaryngology–Head and Neck Surgery
28 August 2020 in 3 Biotech
Various Genome-wide association studies (GWAS) have reported the association of variant rs2494938 with lung cancer. However, genetic association of LRFN2 genetic variation with non-small cell lung cancer (NSCLC) in North Indian population remained unexplored. We conducted a case–control association study using TaqMan-based chemistry in which a total of 619 individuals, 189 NSCLC cases and 430 controls, were genotyped to explore the association of rs2494938 genetic variant of the LRFN2 gene with NSCLC patients from North India. The allele ‘G’ (risk allele) of the genetic variant rs2494938 was significantly associated with the NSCLC [OR = 1.51 (1.18–1.93 at 95% CI); p value = 0.0009]. Genetic association was also explored by applying different genetic models (Dominant, Additive). These results suggest that rs2494938 polymorphism of the LRFN2 gene is a risk factor in the North Indian populations to develop NSCLC. The LD (Linkage Disequilibrium) plot demonstrates the variant and its LD SNPs (r2 > 0.8) and the variant has direct regulatory effect, which could affect the overall physiology of the gene. These findings could be used as diagnostic and prognostic markers in clinical studies of lung cancer patients in North Indian population groups. The present study also provides an important evidence on the genetic etiology of NSCLC in North Indian populations and further expounds GWAS findings on the role of LRFN2 in lung cancer risk. This study provides the holistic view about the non-small cell lung cancer in Jammu and Kashmir, North Indian population and it can be a hallmark of cancer if verified on a very large sample size (cohort).
19 April 2024 in Otolaryngology–Head and Neck Surgery
Objective: To define symptomatology and responses to treatment in chronic sialadenitis from sialolithiasis versus duct stenosis and establish a minimal clinically significant difference (MCID) in the validated Obstructive Salivary Problem Impact Test (SPIT).Study Design: Prospective, cohort.Setting: Tertiary‐care center.Methods: Patients completed the SPIT questionnaire at presentation and 3 to 6 months after surgery. SPIT scores and domains were compared between patients with symptomatic sialolithiasis and those with stenosis of a major salivary gland.Results: Seventy‐nine patients completed the SPIT, including 43 (54%) with sialolithiasis and 36 (46%) with stenosis. Stenosis patients displayed greater baseline scores compared to sialolithiasis patients (45.4 ± 19.9 vs 33.3 ± 18.5, P < .013). Frequency and severity of gland swelling and pain (21.9 ± 8.9 vs 17.1 ± 9.6, P = .02) and functional/psychosocial impact subscores were greater in the stenosis versus sialolithiasis groups (18.0 ± 10.9 vs 11.3 ± 9.4, P < .01). For 43 patients who underwent surgical intervention, SPIT scores improved at 3 to 6 months postoperatively in all domains (−18.6 ± 19.4, P < .01). Degree of improvement did not differ between sialolithiasis versus stenosis groups (−22.0 ± 20.9 vs −13.3 ± 15.8, P = .13). The MCID in SPIT score was found to be −13 points. A postoperative SPIT score of less than 10 suggested symptom resolution.Conclusion: When compared to sialolithiasis, chronic salivary obstruction from stenosis is associated with greater baseline SPIT scores, indicating poorer sialadenitis‐related quality of life due to greater symptom frequency and functional impact. Based on SPIT survey outcomes, a score decrease of 13 points or SPIT score <10 represent significant symptom improvement.